Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
PharmaDoctor™ has responded to the recently published statement by the General Pharmaceutical Council (GPhC) advising pharmacy owners and superintendent pharmacists against the supply of COVID-19 rapid antibody tests through community pharmacy.
The response from PharmaDoctor™ in the form of an open letter to the GPhC is outlined below.
Have your say and write to the editor. With your permission, we will publish your thoughts in our ‘letters to the editor’ section.
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.